Coated-stent makers rush to reassure after inquiry

By Stephen Heuser

Globe Staff / December 12, 2006

E-mail|
Reprints|

Text size – +

Last Thursday, the day the Food and Drug Administration launched a two-day advisory panel on the risks of drug-coated stents, doctors across the country found an e-mail on their computers from stent maker Johnson & Johnson, inviting them to join a conference call about stent safety. (Full article: 722 words)